微创胸骨切开术与常规胸骨切开术用于主动脉瓣置换术的长期结局:一项随机对照试验
MAVRIC试验将270例重度主动脉瓣狭窄患者按1:1随机分为胸骨柄限制性微创胸骨切开组(n=135)和常规正中胸骨切开组(n=135),比较长期全因死亡与再次手术的复合结局。中位随访6.1年时,常规组复合结局发生率为18.5%(25/135),微创组为17%(23/135),两组慢性肾病、脑血管意外、心肌梗死及超声心动图指标均无显著差异。
要点
- 中位随访6.1年,全因死亡与再次手术复合结局在常规组为18.5%(25/135),微创组为17%(23/135),两组无显著差异。
- 两组慢性肾病、脑血管意外和心肌梗死发生率无显著差异。
- 随访超声心动图提示两种入路的主动脉瓣峰值压差、平均压差及主动脉瓣反流发生率无差异。
核心结论
- 在重度主动脉瓣狭窄行单纯主动脉瓣置换术的患者中,胸骨柄限制性微创胸骨切开与常规胸骨切开在中位6.1年随访时的全因死亡、再次手术率、主要不良心血管事件及超声心动图数据方面无显著差异。
研究设计与样本
- 前瞻性、随机、单中心、单盲MAVRIC试验,比较胸骨柄限制性微创胸骨切开与常规正中胸骨切开治疗重度主动脉瓣狭窄。
- 2014年3月至2016年6月共纳入270例患者,按1:1随机分为微创胸骨切开组(n=135)和常规正中胸骨切开组(n=135)。
- 既往报告的主要结局为术后及索引手术后7天内接受红细胞输注的患者比例。
- 本次报告探索性分析采用意向性治疗原则,通过log-rank检验比较两组全因死亡与再次手术的复合终点,并对复合终点各组分进行敏感性分析。
主要发现
- 中位随访6.1年时,全因死亡与再次手术复合结局在常规胸骨切开组发生率为18.5%(25/135),在微创胸骨切开组为17%(23/135)。
- 两组慢性肾病、脑血管意外和心肌梗死发生率无显著差异。
- 随访超声心动图数据提示两种入路的主动脉瓣峰值压差、平均压差及主动脉瓣反流发生率无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aortic valve replacement (AVR) for severe symptomatic aortic stenosis is one of the most common cardiac surgical procedures with excellent long-term outcomes. Multiple previous studies have compared short-term outcomes of AVR with mini-sternotomy versus AVR with conventional sternotomy. We have previously reported the results of the randomized MAVRIC trial, which aimed to evaluate early postoperative morbidity among patients undergoing mini-sternotomy and conventional sternotomy AVR. We now report the long-term all-cause mortality, reoperation, MACE outcomes and echocardiographic data from this trial. METHODS: The prospective, randomized, single-centre, single-blind MAVRIC (manubrium-limited mini-sternotomy versus conventional sternotomy for aortic valve replacement) trial compared manubrium-limited mini-sternotomy and conventional median sternotomy for the treatment of patients with severe aortic stenosis. The previously reported primary outcome was the proportion of patients receiving red cell transfusion postoperatively and within 7 days of the index procedure. Currently reported exploratory analyses of a combined long-term all-cause mortality and reoperation were compared between groups via the log-rank test. Sensitivity analyses reviewed individual components of the combined end point. The primary analysis and long-term exploratory analyses were based on an intention-to-treat principle. RESULTS: Between March 2014 and June 2016, 270 patients were enrolled and randomized in a 1:1 fashion to undergo mini-sternotomy AVR (n = 135) or conventional median sternotomy AVR (n = 135). At the median follow-up of 6.1 years, the composite outcome of all-cause mortality and reoperation occurred in 18.5% (25/135) of patients in the conventional sternotomy group and in 17% (23/135) of patients in the mini-sternotomy group. The incidence of chronic kidney disease, cerebrovascular accident and myocardial infarction was not significantly different between 2 groups. Follow-up echocardiographic data suggested no difference in peak and mean gradients or incidence of aortic regurgitation between 2 approaches. CONCLUSIONS: This exploratory long-term analysis demonstrated that, in patients with severe aortic stenosis undergoing isolated AVR, there was no significant difference between manubrium-limited mini-sternotomy and conventional sternotomy with respect to all-cause mortality, rate of reoperation, MACE events and echocardiographic data at the median of 6.1-year follow-up.
引用
- Telyuk P, Hancock H, Maier R, et al. Long-term outcomes of mini-sternotomy versus conventional sternotomy for aortic valve replacement: a randomized controlled trial. Eur J Cardiothorac Surg. 2022. PMID: 36394261. doi:10.1093/ejcts/ezac540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。